Class / Patent application number | Description | Number of patent applications / Date published |
514733000 | Acyclic carbon to carbon unsaturation | 52 |
20090005461 | Use of Cannabidiol in the Treatment of Hepatitis - Cannabinoids are known to interact with CB1 and CB2 receptors expressed in the nervous and immune systems mediating a wide range of effects, including anti-inflammatory properties. However, cannabinoids that bind are also psychoactive thereby limiting their clinical use. Cannabidiol (CBD) is the most abundant nonpsychotropic plant cannabinoid but has not been studied as extensively as Δ | 01-01-2009 |
20090012183 | Composition comprising polyphenol - A food product comprising from 0.05 to 1 wt % of trans-resveratrol can advantageously be used to control blood pressure. Preferred food products are spreads or drinks. | 01-08-2009 |
20090036545 | Skin appearance through gene manipulation - The present invention relates to a method for treating, preventing and improving the condition and/or aesthetic appearance of aging skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, through meroterpene induced gene manipulation. | 02-05-2009 |
20090082473 | Composition comprising resveratol and its topical use thereof for reducing human hair growth - A cosmetic and therapeutic method for reducing human hair growth comprises selecting an area of skin from which reduced hair growth is desired and applying to the area of skin a composition comprising resveratrol in an amount effective to reduce hair growth. | 03-26-2009 |
20090156689 | METHOD OF ENHANCING BIOLOGICAL ACTIVITY OF PLANT EXTRACTS - The present invention relates to a method of modulating a selected biological activity of a naturally occurring material having one or more biological activities in an extract of the naturally occurring material, the method comprising incubating the extract in a medium in the presence of an aerobically metabolizing microorganism, under suitable aerobic conditions, for a period of time sufficient to modulate the selected activity with respect to baseline activity of the unincubated extract. The invention also relates to the bioconverted material so prepared, and the use of same in cosmetic or pharmaceutical compositions. | 06-18-2009 |
20100010099 | MEDIUM AND DEVICE FOR PROLIFERATION OF STEM CELLS AND TREATMENT OF CANCER-RELATED STEM CELL WITH RESVERATROL - The invention relates to a device for selecting stem cells with a serum free medium for amplification of stem cells. The invention also relates to a method of treating or preventing diseases caused by cancer-related stem cells. The invention further provides a method of enhancing radiosensitivity of cancer-related stem cells comprising radiotherapy with resveratrol, and the cancer-related stem cell has stronger drug resistance. The present invention further provides that resveratrol promotes differentiation and inhibits teratoma/tumor formation in induced pluripotent stem cells (iPS) and embryonic stem cells | 01-14-2010 |
20100016445 | TRANSDERMAL DIETHYLSTILBESTROL FOR TREATING PROSTATE CANCER - Methods for treating prostate cancer comprising transdermally administering a therapeutically effective amount of diethylstilbesterol (DES), or a pharmaceutically acceptable salt or complex thereof, to a subject. In one embodiment, transdermally administered DES may be used to treat hot flashes in castrate prostate cancer patients. In another embodiment, transdermal DES may be administered as a therapy while avoiding testosterone surge and clinical tumor flare (for example, for treating symptomatic locally advanced prostate cancer, treating metastatic prostate cancer, or in a subject who is contraindicated for conventional therapy such as ADT therapy, particularly GnRH (gonadotropin-releasing hormone) therapy). In a further embodiment, transdermal DES may be administered to treat osteoporosis in men with prostate cancer. The transdermal DES may be used as a front line hormonal therapy or a second line hormonal therapy for treating prostate cancer. | 01-21-2010 |
20100130622 | PHARMACEUTICAL PREPARATION FOR PREVENTING AND/OR TREATING PERIODONTAL DISEASE, AGENT FOR ORAL HYGIENE COMPRISING THEREOF, AND FOOD COMPRISING THEREOF - The present invention provides a pharmaceutical composition for preventing and/or treating periodontal disease comprising at least one having dental root-periodontal tissue formation promotion effect selected from the group consisting of a compound shown in a following formula (I). | 05-27-2010 |
20100130623 | PRODUCTION OF STILBENES IN PLANT HAIRY ROOT CULTURES AND OTHER ROOT CULTURES - Improved methods for production of stilbenoids including resveratrol, pinosylvin and their respective derivatives are provided, including producing root cultures from plant cells and eliciting production of the stilbenes. The plant cells in an embodiment are contacted with substances which elicit production of the stilbenoid compounds. | 05-27-2010 |
20100184869 | METHOD AND KIT FOR DETERMINING SIRTUIN MODULATING AGENTS, SIRTUIN MODULATING PROCEDURE, SIRTUIN MODULATING COMPOUNDS AND COMPOSITIONS INCLUDING THE SAME - A kit and a method for determining modulating agents of sirtuins; specifically, the modulation of sirtuin expression, by way of the detection and comparison of mRNAs in the sirtuins and β-actin. A process for modulating the activity of sirtuins, as well as pharmaceutical compounds and compositions capable of modulating the gene expression of sirtuins. | 07-22-2010 |
20100190865 | METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar - The invention provides in part dialkoxybenzene and eugenol compounds for controlling infestation by a | 07-29-2010 |
20100210735 | Modulating the Activity of Nuclear Receptors in Order to Treat Hypoxia-Related Disorders - The subject invention provides methods for treating hypoxia-related conditions by modulating the activity of certain nuclear receptors. Specifically exemplified herein are materials and methods for treating cancer and other pathological conditions involving hypoxia and/or abnormal or excessive neovascularization. | 08-19-2010 |
20100273895 | FORMULATIONS OF CANNABIDIOL AND PRODRUGS OF CANNABIDIOL AND METHODS OF USING THE SAME - Described herein are pharmaceutical compositions comprising a cannabinoid, such as cannabidiol or a cannabidiol prodrug, which is metabolized to cannabidiol, and a penetration enhancer. Also described herein are methods of using the same. One embodiment described herein relates to the transdermal or topical administration of pharmaceutical compositions comprising a cannabinoid, such as cannabidiol or a cannabidiol prodrug, and a penetration enhancer to a person in need thereof. | 10-28-2010 |
20100292345 | THERAPEUTIC USES OF CANNABIGEROL - The present invention relates to the use of the cannabinoid cannabigerol (CBG) in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from concurrent agonism of the CBi and the CB2 cannabinoid receptors. Such diseases or conditions to be treated are taken from the group: pain, neurodegenerative disease, ischemic disease, brain injury or damage, acquired brain injury, age related inflammatory or autoimmune disease, cachexia, nausea and vomiting, glaucoma, movement disorders, rheumatoid arthritis, asthma, allergy, psoriasis, Crohn's disease, systemic lupus erythematosus, diabetes, cancer, osteoporosis, renal ischemia and nephritis. | 11-18-2010 |
20110021640 | Mechanism-based biochemical standardization of resveratrol products and their uses thereof - The present invention pertains to methods (a) Inhibition of adenosine deaminase by resveratrol products including botanical extracts containing resveratrol and/or oxyresveratrol; (b) Biochemical Standardization of these products as Enzyme Inhibitory Units (EIU) per mg or gram; and (c) Their uses thereof. | 01-27-2011 |
20110039945 | COMPOSITIONS CONTAINING RESVERATROL AND PECTIN - The present invention relates to compositions, preferably in the form of a powder and/or granules, which contain resveratrol and pectin, and a process for the manufacture of such compositions. | 02-17-2011 |
20110039946 | METHOD OF IMPROVING ATOPIC DERMATOLOGICAL DISEASES, IN WHICH A COMPOSITION COMPRISING MAGNOLOL, HONOKIOL OR A COMBINATION THEREOF IS ADMINISTERED TO A PATIENT WITH ATOPIC DERMATOLOGICAL DISEASES - Disclosed is a method of improving atopic dermatological diseases, in which a composition comprising magnolol, honokiol or a combination thereof is administered to a patient with atopic dermatological diseases. | 02-17-2011 |
20110130468 | HYDROXYLATED TOLANS AND RELATED COMPOUNDS IN THE TREATMENT OF A CANCER - Compounds of the hydroxytolan family kill tumor cells, inhibit tumor growth and development, and are thus useful in method for treating a tumor or cancer in subjects in need thereof. These compounds are also active in preventing or treating a variety of skin diseases and conditions. The most preferred hydroxytolan compounds are 4,4′-dihydroxytolan. (KST-201), 4 hydroxy 4′ trifluoromethyltolan or 4′ hydroxy 4 trifluoromethyltolan (KST-213), 3,4′,5-trihydroxytolan or 3′,4,5′-trihydroxytolan (KST-301) and 3,3′,5,5′-tetrahydroxytolan (KST-401). The compounds and methods of using them alone and in combination with ascorbate and certain cyclic compounds to inhibit the development, growth or metastasis of tumor/cancer or preneoplastic cells, or to prevent or treat skin disorders in a subject are disclosed. | 06-02-2011 |
20110130469 | COMPOSITIONS AND METHODS RELATING TO RESVERATROL - The present invention relates to compositions and methods comprising resveratrol and uses thereof. Some embodiments include compositions and methods with increased bioavailability of resveratrol. Certain embodiments include compositions comprising resveratrol and a solubilizer. Particular embodiments include transmucosal delivery of resveratrol from the composition. | 06-02-2011 |
20110281957 | ENHANCED BIOACTIVE FORMULATIONS OF RESVERATROL - Methods and formulations for increasing the water solubility and/or bioavailability of resveratrol are disclosed. The formulations may be employed to treat a disease states, including cancer. | 11-17-2011 |
20110319497 | AMPK ACTIVATOR - A method for suppressing fatty liver in a subject in need thereof by administering to the subject an effective amount of resveratrol. | 12-29-2011 |
20120016037 | Method for prevention and treatment of Alzheimers - Elderly individuals are administered dosages of Trans-resveratrol totaling between about 250 mg and 1 gram per day. Typically about 500 mg of Trans-resveratrol are orally administered to such individuals on a daily basis. As a result of the chemical action of Trans-resveratrol in the bodies of the subjects, Alzheimer's disease is prevented, or if already present, advancement is retarded and the existing mentally debilitating conditions of Alzheimer's disease are treated. A subject receiving the Trans-resveratrol experiences a reduction or illumination of the effects of Alzheimer's disease. | 01-19-2012 |
20120035272 | Method to Ameliorate Oxidative Stress and Improve Working Memory Via Pterostilbene Administration - Disclosed is a pharmaceutical composition for treating oxidative stress comprising a therapeutically effective amount of a substantially pure compound of pterostilbene and a physiologically acceptable carrier. Pterostilbene is administered in an amount between about 2.5 mg to about 10 mg per kilogram of subject body weight. Also disclosed is a method for increasing a working memory of a subject, the method comprising administrating an effective amount of a substantially pure compound of pterostilbene, wherein the working memory for a subject increase and the therapeutic effectiveness is about 10 mg of pterostilbene per kilogram of subject body weight. | 02-09-2012 |
20120077884 | COCCIDIOSIS CONTROLLING AGENT AND FEED CONTAINING THE SAME - An object of the present invention is to provide: a coccidiosis controlling agent which is excellent in safety, is free of problems such as side-effects, does not cause effect reduction or the like due to the acquisition of resistance to a medicament, and exhibits a high preventive effect and a high treatment effect against coccidiosis; a feed for an animal containing the anticoccidial composition; and a method for raising an animal using the coccidiosis controlling agent and the feed. In order to solve the above-mentioned problem, provided is a coccidiosis controlling agent for an animal, containing heated cashew nut shell liquid and/or cardanol. | 03-29-2012 |
20120088841 | COMPOSITION AND A METHOD OF TREATING CNS DISORDERS AND HYPERPIGMENTATION - The present invention relates to a method of treating CNS disorders, particularly Alzheimer's disease. The method comprise step of administering to a subject in need thereof a therapeutically effective amount of hydroxychavicol and/or its derivatives or a composition comprising hydroxychavicol and/or its derivatives optionally along with pharmaceutically acceptable excipients. The invention also relates to use of hydroxychavicol and/or its derivatives for treating hyperpigmentation. | 04-12-2012 |
20120165412 | Use of Resveratrol or Another Hydroxylated Stilbene For Preserving Cognitive Functioning - The present invention relates to the use of an hydroxylated stilbene, in particular resveratrol, in the manufacture of a neutraceutical composition for increasing the microvascular plasticity and/or microvessel density, and/or decreasing the microvessel abnormalities in the brain, in particular in the hippocampus of a mammal, in particular for the treatment of age- and condition-related decline in brain neuronal function and/or cognitive functioning in a mammal. In particular, the condition is selected from the group of Alzheimer's Disease, dementia, depression, sleep disorders, impaired memory function, psychoses, Parkinson's disease, Huntington's chorea, epilepsy, schizophrenia, paranoia, ADHD and anxiety. | 06-28-2012 |
20120202891 | Cannabinoid-Containing Compositions and Methods for Their Use - This invention relates to cannabinoid-containing compositions, particularly cannabinoid-containing gel formulations and methods for the treatment of traumatic injury, e.g., strains, sprains and contusions, and disease conditions, e.g., arthritis, particularly osteoarthritis. The methods involve topically applying a cannabinoid or a cannabinoid-containing composition to a subject's skin near, or distant from, the area of the injury or the area affected by the disease condition, e.g., an arthritic joint. The cannabinoid-containing composition is preferably a pharmaceutically acceptable gel containing a therapeutically effective amount of a cannabinoid sufficient to alleviate the symptoms associate with the injury or disease condition. | 08-09-2012 |
20120202892 | Cannabinoid-Containing Compositions and Methods for Their Use - This invention relates to cannabinoid-containing compositions, particularly cannabinoid-containing gel formulations and methods for the treatment of traumatic injury, e.g., strains, sprains and contusions, and disease conditions, e.g., arthritis, particularly osteoarthritis. The methods involve topically applying a cannabinoid or a cannabinoid-containing composition to a subject's skin near, or distant from, the area of the injury or the area affected by the disease condition, e.g., an arthritic joint. The cannabinoid-containing composition is preferably a pharmaceutically acceptable gel containing a therapeutically effective amount of a cannabinoid sufficient to alleviate the symptoms associate with the injury or disease condition. | 08-09-2012 |
20120302646 | Use of Cannabidiol in the Treatment of Hepatitis - Cannabinoids are known to interact with CB1 and CB2 receptors expressed in the nervous and immune systems mediating a wide range of effects, including anti-inflammatory properties. However, cannabinoids that bind CB1 are also psychoactive thereby limiting their clinical use. Cannabidiol (CBD) is the most abundant nonpsychotropic plant cannabinoid but has not been studied as extensively as Δ | 11-29-2012 |
20120302647 | SYNTHESIS OF MAGNOLOL AND ITS ANALOGUE COMPOUNDS - A method is described for producing magnolol, or a derivative or analogue thereof. The method includes obtaining MOM ether of 5,5′-diallylbiphenyl-2,2′-diol or a derivative or analogue thereof and subsequently converting the MOM ether of 5,5′-diallylbiphenyl-2,2′-diol into magnolol or a derivative or analogue thereof. | 11-29-2012 |
20130023590 | AQUEOUS COMPOSITIONS COMPRISING RESVERATROL AND METHODS FOR MAKING THEM - A method is provided for solubilizing and stabilizing resveratrol in aqueous solutions free of solvents other than water. Resveratrol is solubilized and stabilized by forming complex structures with positively-charged substances in solution, such as caffeine, vitamins, amino acids and/or metallic ions. Additionally, these solutions can be further enhanced by adding any combination of health-promoting compounds, such as teas, plants and fruits, juices, protein or fiber. Aqueous solutions prepared by the method are also disclosed. | 01-24-2013 |
20130165529 | PICEATANNOL-CONTAINING COMPOSITION AND METHOD OF PRODUCING PICEATANNOL-CONTAINING COMPOSITION - Provided are a piceatannol-containing composition which is a composition originating in a natural material and containing piceatannol at a high concentration, and a method of producing the piceatannol-containing composition. A piceatannol-containing composition which contains 0.0001 to 99.9% by mass of piceatannol is obtained by extracting passion fruit seeds. The extraction of piceatannol is carried out by grinding the passion fruit seeds, adding at least one solvent selected from an aqueous alcohol-based solvent and an aqueous ketone-based solvent and agitating to thereby extract piceatannol into the above-described solvent. In this case, it is preferable to conduct stepwise extraction by using both of the aqueous alcohol-based solvent and the aqueous ketone-based solvent. | 06-27-2013 |
20130253071 | Methods and Compositions for Prevention and Treatment of Inflammatory Disease, Autoimmune Disease and Transplant Rejection - The invention provides compositions and methods for reducing one or more symptoms of an autoimmune disease, inflammatory disease, and/or transplant rejection, by the administration to a subject in need thereof a pharmaceutically effective amount of a purified compound of any one of Formulae A-E. The invention's methods are useful for the prevention, amelioration, and treatment of autoimmune disease, inflammatory disease, and/or transplant rejection. | 09-26-2013 |
20130324616 | USE OF UV-FILTERS TO STABILIZE RESVERATROL IN TOPICAL COSMETIC COMPOSITIONS - Use of UV-filters to stabilize resveratrol in topical cosmetic compositions and to improve the efficacy of topical cosmetic skin whitening compositions containing resveratrol as skin whitening agent. | 12-05-2013 |
20130324617 | CROWN-LIKE STRUCTURES AS A BIOMARKER FOR CANCER RISK AND CANCER PROGNOSIS - Chronic inflammation increases the risk of several epithelial malignancies. The present invention provides methods for determining cancer risk in a patient which comprises detecting the presence of crown-like structures (CLS), methods for treating cancer associated with CLS presence, methods for determining cancer risk in a patient by quantifying the number of CLS in a sample of adipose tissue of the patient, methods of determining prognosis of a patient with breast cancer or other cancers by detecting CLS, and screening methods for anti-cancer agents or agents that inhibit or reduce CLS formation or consequences thereof. | 12-05-2013 |
20130331460 | CHRYSOPHAENTIN ANALOGS THAT INHIBIT FTSZ PROTEIN - Embodiments of antimicrobial chrysophaentin compounds, pharmaceutical compositions including the chrysophaentin compounds, methods for using the chrysophaentin compounds, and methods for synthesizing the chrysophaentin compounds are disclosed. Certain embodiments of the chrysophaentin compounds inhibit FtsZ protein, thereby inhibiting the growth of clinically relevant bacteria, including drug-resistant strains. | 12-12-2013 |
20140005275 | TOPICAL APPLICATION OF 1-HYDROXYL 3,5-BIS(4'HYDROXYL STYRYL)BENZENE | 01-02-2014 |
20140005276 | COMPOSITIONS COMPRISING SUBSTITUTED PHENOLS AND TOPICAL APPLICATION THEREOF | 01-02-2014 |
20140011889 | Resveratrol-Containing Compositions and Methods of Use for Cardiac-Related Diseases - A resveratrol-containing composition capable of providing a therapeutic benefit to a subject such as modulation of a biological activity, improving cell transplantation therapy, or improving macular degeneration or dystrophy treatments. The compositions comprise trans-resveratrol, a metal chelator, and one or more additional antioxidants such as phenolic antioxidants or vitamin D. | 01-09-2014 |
20140057994 | COMPOSITIONS COMPRISING SUBSTITUTED PHENOLS AND TOPICAL APPLICATION THEREOF - The present invention relates to compositions comprising substituted phenols, and methods of treating human skin and signs of skin aging using said compositions. | 02-27-2014 |
20140235731 | NOVEL COMPOSITIONS - The present invention relates to a fluid composition comprising water and a self-emulsifying cosmetic base consisting of resveratrol, a liquid phosphate ester surfactant, at least one cosmetic oil and optionally a co-emulsifier. The present invention also relates to the process to make such fluids. | 08-21-2014 |
20140243424 | CATECHOL DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES - Methods of treating or suppressing oxidative stress disorders affecting normal electron flow in the cells, including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases, diseases of aging and diseases caused by reactive oxygen species are disclosed, as well as compounds useful in the methods of the invention, such as such as catechol or ortho-quinone derivatives of Formula (I). | 08-28-2014 |
20140303260 | PHARMACEUTICAL COMPOSITIONS OF RESVERATROL - A pharmaceutical composition for administering a therapeutically effective amount of resveratrol or a functionally equivalent analogue or derivative thereof to a subject. The absorption of resveratrol occurs through the subject's buccal/sublingual membranes, thereby by-passing first pass metabolism by the liver. | 10-09-2014 |
20140371328 | NOVEL COMPOUNDS - The present invention relates to topical compositions comprising resveratrol in a liquid crystal gel network formed by a phosphate ester surfactant and a co-emulsifier. The present invention also relates to the process to make such compositions. | 12-18-2014 |
20160022602 | COMPOSITIONS OF BAKUCHIOL AND METHODS OF MAKING THE SAME - The present invention provides compositions of bakuchiol (UP246) having low levels of impurities, particularly furanocoumarin impurities. The present invention further provides improved methods for the isolation, purification and analysis of compositions of bakuchiol. Finally, the present invention provides methods for using the purified bakuchiol compositions and formulations thereof for the prevention and treatment of various diseases and conditions mediated by cyclooxygenase (COX), lipoxygenase (LOX), minor inflammatory conditions and various microbial infections. The methods of this invention are comprised of administering to a host in need thereof an effective amount of the composition of this invention together with a pharmaceutically acceptable carrier. | 01-28-2016 |
20160030363 | Tincture For Infusing Resveratrol And Methods Of Use - Methods and formulations for infusing bioavailable resveratrol tinctures into food, beverage, cosmetic or drug products with minimal effect on the alcohol by volume of the product is provided. A resveratrol tincture includes an amount of trans-resveratrol mixed with a solvent of pure, or majority by weight, ethanol. The tincture is added to various food and beverages to make a bioavailable amount of trans-resveratrol to be absorbed and metabolized by the body providing demonstrated health benefits. | 02-04-2016 |
20160038437 | PROCESSES AND APPARATUS FOR EXTRACTION OF ACTIVE SUBSTANCES AND ENRICHED EXTRACTS FROM NATURAL PRODUCTS - Processes for preparing extracts of natural products such as plant material, and for preparing purified extracts from crude extracts of natural products, by extraction with hot gas. Apparatus suitable for use in preparing extracts of natural products are also described. | 02-11-2016 |
20160051491 | NOVEL USE OF PINOSYLVIN FOR ANGIOGENESIS PROMOTION - The present invention relates to a pharmaceutical composition for preventing or treating angiogenesis-dependent diseases containing pinosylvin or a pharmaceutically acceptable salt thereof as an active ingredient, a food composition for preventing or improving angiogenesis-dependent diseases containing pinosylvin or a pharmaceutically acceptable salt thereof as an active ingredient, a method for treating angiogenesis-dependent diseases including administering the pharmaceutical composition to a subject suspected of having the angiogenesis-dependent diseases, and a method for promoting angiogenesis including administering pinosylvin or a pharmaceutically acceptable salt thereof to a subject in need of angiogenesis promotion. | 02-25-2016 |
20160151302 | A DERMAL MATRIX AND PRODUCTION METHOD THEREOF HAVING SYNERGISTIC EFFECTS COMPRISING MICROPARTICLES WHICH PROVIDES TISSUE REPAIR | 06-02-2016 |
20160184237 | METHODS OF GROWING CANNABACEAE PLANTS USING ARTIFICIAL LIGHTING - This invention is directed to a method of growing a plant from the Cannabaceae family, the cultivar or composition produced therefrom, wherein the plant is exposed to artificial lighting of different intensities based on spacing, growth phase, and flowering yield. | 06-30-2016 |
20170231922 | 3, 5-DIHYDROXY-4-ISOPROPYLSTILBENE (DHIS) AS MITICIDAL AGENT AND ITS THERAPEUTIC USES | 08-17-2017 |
20180021267 | COMPOSITIONS AND METHODS RELATING TO RESVERATROL | 01-25-2018 |